The PROGENI Family Study is part of a larger consortium that is studying a gene shown to be important in Parkinson's disease, called LRRK2. People who have a defect in the LRRK2 gene will often develop Parkinson's disease. Eligible participants will be asked to complete a single Study Visit at an affiliated research facility closest to their home.
Participants will be asked to complete a family history questionnaire, which will gather information about their family history of Parkinson's disease and related disorders. They will be asked to complete a single Study Visit, during which they will be asked to do some or all of the following: 1. Complete questionnaires regarding Parkinson's disease symptoms, medical history, mood, sleep, mental status, and activity level. 2. Be given a brief standard neurological examination. 3. Be given a scratch and sniff smell identification test. 4. Be asked to give a sample of approximately 2 tablespoons of blood. 5. Be asked to give a urine sample of approximately 1 tablespoon of urine.
Study Type
OBSERVATIONAL
Enrollment
81
Cleveland Clinic Florida
Weston, Florida, United States
Indiana University Medical Center
Indianapolis, Indiana, United States
University of Iowa Hospitals
Iowa City, Iowa, United States
Observation and biological specimen collection
Time frame: 1 time
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kansas University Medical Center
Kansas City, Kansas, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
University of Nebraska
Omaha, Nebraska, United States
Beth Israel Medical Center
New York, New York, United States
Medical University of Ohio
Toledo, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Alberta
Edmonton, Alberta, Canada